halothane has been researched along with Epidermolysis Bullosa Dystrophica in 1 studies
Epidermolysis Bullosa Dystrophica: Form of epidermolysis bullosa characterized by atrophy of blistered areas, severe scarring, and nail changes. It is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms. All forms of dystrophic epidermolysis bullosa result from mutations in COLLAGEN TYPE VII, a major component fibrils of BASEMENT MEMBRANE and EPIDERMIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorne, R | 1 |
| Tassaux, D | 1 |
| Ravat, F | 1 |
| Pommier, C | 1 |
| Bertrix, L | 1 |
1 other study available for halothane and Epidermolysis Bullosa Dystrophica
| Article | Year |
|---|---|
[Surgery for epidermolysis bullosa in children: value of the association of inhalation anesthesia and locoregional anesthesia].
Topics: Anesthesia, Conduction; Anesthesia, Inhalation; Child; Child, Preschool; Epidermolysis Bullosa Dystr | 1994 |